Prevalence of Tuberculosis, Rifampicin resistant Tuberculosis and associated risk factors in Presumptive Tuberculosis patients attending some hospitals in Kaduna, Nigeria
Keywords:Tuberculosis, Rifampicin resistance, GeneXpert, Ziehl Neelsen test, Risk factors, Kaduna State
Background: This study was carried out to determine the prevalence of Tuberculosis and Mycobacterium tuberculosis resistance to Rifampicin using GeneXpert in presumptive tuberculosis patients attending some hospitals in Kaduna, Nigeria.
Methods: The study design was cross sectional. A total of 198 sputum samples were collected from participants who had been administered questionnaires and screened using Ziehl Neelsen Acid Fast Bacilli (ZN AFB) method and GeneXpert molecular technique. Data obtained from this study was analysed using the Statistical Package for the Social Sciences 23(SPSS® package version 23 Inc. Chicago Illinois, USA).
Results: Data obtained showed that using GeneXpert technique, the overall prevalence of TB and Rifampicin resistant TB (RRTB) was 40.4% and 1.25% respectively. A higher prevalence rate was reported among male subjects (47.2%), age group 31-40 (50.9%), those who earned less than 20,000 Naira monthly (41.8%), HIV positive subjects (54.5%), subjects that smoke cigarettes (72.2%) and those that had previous contact with someone living with TB infection (82.4%). The independent variables that were significantly associated with the rate of occurrence of TB (p<0.05 at 95% C.I) were age, gender, HIV status, smoking behaviour, and previous contact with someone having TB.
Conclusions: This study indicates high burden of TB and a low burden of rifampicin resistant tuberculosis among the participants. It highlights the need for rapid detection of TB and Rifampicin resistant strains using GeneXpert or other molecular techniques for TB diagnosis as key to early access to therapy; it will also improve treatment outcomes and decrease transmission rates.
- 2023-08-25 (2)
- 2023-07-10 (1)
How to Cite
Copyright (c) 2023 Journal and Publisher
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to firstname.lastname@example.org.